Lakewood-Amedex Biotherapeutics Inc. (LABT)

Lakewood-Amedex Biotherapeutics Inc. is a clinical-stage pharmaceutical company developing anti-infective drugs. Its work is based on a class of synthetic compounds called bisphosphocins, which are designed to kill bacteria by disrupting their cell membranes, an approach intended to be effective against drug-resistant pathogens.

The company has studied its candidates as topical treatments for infections such as those in diabetic foot ulcers and other bacterial conditions. It is based in Florida, and its common stock is listed on the Nasdaq.